期刊文献+

归脾汤加减防治非小细胞肺癌化疗后骨髓抑制28例临床观察 被引量:3

Clinical effect of modified Guipi decoction in prevention and treatment of bone marrow suppression after chemotherapy for non-small cell lung cancer:An analysis of 28 cases
原文传递
导出
摘要 目的:探讨归脾汤加减防治非小细胞肺癌化疗后骨髓抑制的临床效果。方法:将56例非小细胞肺癌患者随机分为治疗组和对照组,每组各28例。对照组采用吉西他滨+顺铂(GP)方案治疗,治疗组在对照组基础上加用归脾汤加减治疗,比较2组骨髓抑制情况、血常规(白细胞、血红蛋白、血小板水平)及Karnofsky功能状态(KPS)评分。结果:骨髓抑制发生率治疗组为57.14%(16/28),低于对照组的85.71%(24/28),差异有统计学意义(P<0.05)。2组白细胞、血红蛋白、血小板水平治疗前后组内比较及治疗后组间比较,差异均有统计学意义(P<0.05)。治疗后,治疗组KPS评分高于对照组,差异有统计学意义(P<0.05)。结论:归脾汤加减可有效缓解非小细胞肺癌患者化疗后的骨髓抑制,改善血常规指标,降低骨髓抑制程度,提高生活质量。 Objective:To investigate the clinical effect of modified Guipi decoction in the prevention and treatment of bone marrow suppression after chemotherapy for non-small cell lung cancer.Methods:A total of 56 patients with nonsmall cell lung cancer were randomly divided into treatment group and control group,with 28 patients in each group.The patients in the control group were given the gemcitabine+cisplatin regimen,and those in the treatment group were given modified Guipi decoction in addition to the treatment in the control group.The two groups were compared in terms of bone marrow suppression,routine blood test results(white blood cell count,hemoglobin,and platelet level),and Karnofsky Performance Scale(KPS)score.Results:The treatment group had a significantly lower bone marrow suppression rate than the control group[57.14%(16/28)vs 85.71%(24/28),P<0.05].After treatment,both groups had significant changes in white blood cell count,hemoglobin,and platelet level,and there were significant differences in these indices between the two groups after treatment(P<0.05).After treatment,the treatment group had a significantly higher KPS score than the control group(P<0.05).Conclusion:In patients with bone marrow suppression after chemotherapy for non-small cell lung cancer,Guipi decoction can effectively alleviate symptoms,improve routine blood test results,reduce the degree of bone marrow suppression,and enhance quality of life.
作者 彭为 PENG Wei(Changsha Municipal Hospital of Traditional Chinese Medicine,Changsha 410199,Hunan,China)
机构地区 长沙市中医医院
出处 《湖南中医杂志》 2023年第10期8-10,共3页 Hunan Journal of Traditional Chinese Medicine
关键词 非小细胞肺癌 化疗 骨髓抑制 中西医结合疗法 归脾汤加减 non-small cell lung cancer chemotherapy bone marrow suppression integrated traditional Chinese and Western medicine therapy Guipi decoction
  • 相关文献

参考文献6

二级参考文献105

  • 1吴应龙.归脾汤联合多潘立酮治疗伴抑郁或焦虑的功能性消化不良疗效观察[J].中国药物与临床,2011,11(S1):24-25. 被引量:2
  • 2吴一龙,蒋国梁,廖美琳,周清华,陆舜,王绿化,张力,无.非小细胞肺癌孤立性转移处理共识[J].循证医学,2007,7(2):109-111. 被引量:23
  • 3Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014[J]. CA Cancer J C/in, 2014, 64(1):9-29. 被引量:1
  • 4Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: An analysis of the Surveillance, Epidemiology, and End Results database[J]. J Clin Oncol, 2007, 25(35):5570-5577. 被引量:1
  • 5Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortality in the United States, 1930-1998[J]. Cancer, 2003, 97(12):3133-3275. 被引量:1
  • 6Davidoff AJ, Tang M, Seal B, et al. Chemotherapy and survival benefit in elderly patients with advanced non- small cell lung cancer[J].J Clin Onto/, 2010, 28(13):2191-2197. 被引量:1
  • 7Davidoff AJ, Gardner .IF, Seal B, et a/. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer[J].J Thorac Oncol, 2011,6(5):934-941. 被引量:1
  • 8Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer- treatment trials[J]. N EnglJ Med, 1999, 341 (27):2061-2067. 被引量:1
  • 9Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine italian Study Group[J]. J Natl Cancer Inst, 1999, 91(1):66-72. 被引量:1
  • 10Ansari RH, Socinski MA, Edelman MJ, et al. A retrospective analysis of outcomes by age in a three-arm phase m trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplati'n for advanced non-small cell lung cancer[J]. Crit Rev Oncol Hematol, 2011,78(2):1 62-1 71. 被引量:1

共引文献919

同被引文献63

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部